Transcriptional coregulator RIP140: an essential regulator of physiology

10.1016/j.puhe.2009.07.009

Aziz, 2015, Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo, Oncotarget, 6, 39714, 10.18632/oncotarget.5356

10.1210/mend-5-5-619

10.1002/hep.22383

Brou, 1993, Distinct TFIID complexes mediate the effect of different transcriptional activators, EMBO Journal, 12, 489, 10.1002/j.1460-2075.1993.tb05681.x

10.1038/nature12113

10.1093/nar/gkh524

10.1073/pnas.91.21.10009

Cavailles, 1995, Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor, EMBO Journal, 14, 3741, 10.1002/j.1460-2075.1995.tb00044.x

10.1210/mend-5-1-100

10.1038/nri3071

10.1016/j.mce.2004.07.001

10.1016/j.mce.2012.03.023

10.1074/jbc.M313906200

10.1128/MCB.25.21.9383-9391.2005

10.1016/j.tem.2006.06.008

10.1210/me.11.9.1332

10.1056/NEJMoa0810780

10.1530/JME-14-0080

10.1146/annurev-med-051812-145316

10.1016/j.cell.2012.06.013

10.1210/me.2007-0103

10.1371/journal.pone.0035839

10.1210/me.2012-1351

10.1111/j.1601-183X.2011.00731.x

Feng, 2014, Receptor-interacting protein 140 attenuates endoplasmic reticulum stress in neurons and protects against cell death, Nature Communications, 5, 4487, 10.1038/ncomms5487

Feng, 2015, Behavioral stress reduces RIP140 expression in astrocyte and increases brain lipid accumulation, Brain, Behavior, and Immunity, 46, 270, 10.1016/j.bbi.2015.02.008

10.3945/ajcn.110.001917

Ferreira, 2014, New target genes in endometrial tumors show a role for the estrogen-receptor pathway in microsatellite-unstable cancers, Human Mutation, 35, 1514, 10.1002/humu.22700

10.1093/cvr/cvp418

Fritah, 2011, Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function, Cardiovascular Research, 86, 443, 10.1093/cvr/cvp418

10.1371/journal.pone.0032520

10.1038/nature08497

10.1038/ni.2419

Gibson, 2016, The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis, Nature Genetics, 48, 848, 10.1038/ng.3602

10.1016/0092-8674(90)90139-6

10.1074/mcp.M500236-MCP200

10.1093/nar/gkl1147

10.1126/science.8197458

10.1128/MCB.00504-08

10.1186/bcr2839

10.1038/42750

10.1038/387043a0

10.1038/leu.2011.125

10.1210/me.2007-0213

10.1016/j.cellsig.2008.07.001

10.1038/ni.2238

10.2337/db14-1117

10.1074/jbc.272.47.29821

10.1016/0092-8674(94)90404-9

10.1038/msb.2010.109

10.1210/me.11.2.193

10.1016/j.tibs.2011.01.001

10.1210/me.2013-1254

Lapierre, 2014, RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis, Journal of Clinical Investigation, 124, 1899, 10.1172/JCI65178

Lapierre, 2015, Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia, Journal of Hematology and Oncology, 8, 20, 10.1186/s13045-015-0116-6

Lapierre, 2015, The emerging role of the transcriptional coregulator RIP140 in solid tumors, Biochimica et Biophysica Acta, 1856, 144

10.2353/ajpath.2007.061010

10.1016/S0378-1119(00)00024-X

10.1210/en.143.2.700

10.1073/pnas.0401013101

10.2337/db14-0619

Liu, 2015, Injecting engineered anti-inflammatory macrophages therapeutically induces white adipose tissue browning and improves diet-induced insulin resistance, Adipocyte, 4, 123, 10.4161/21623945.2014.981438

Liu, 2015, M1-M2 balancing act in white adipose tissue browning – a new role for RIP140, Adipocyte, 4, 146, 10.4161/21623945.2014.981428

10.1016/j.molcel.2007.08.012

10.1172/JCI29881

10.1530/JME-13-0227

10.1038/nri2448

10.1016/S0092-8674(00)80218-4

10.1210/en.2010-0081

10.1016/j.tem.2013.05.001

10.1242/dev.085720

10.1016/j.ceb.2008.04.005

10.1210/en.2003-0487

10.1210/en.2002-220435

10.1126/science.1230721

10.1200/JCO.2005.03.2755

10.1126/science.270.5240.1354

10.1126/science.1092463

10.1093/nar/gkp780

10.1210/me.2011-1072

10.1172/JCI26040

10.1016/S0092-8674(00)81410-5

10.1055/s-2007-980217

10.1172/JCI41350

10.1210/me.2015-1005

Rosell, 2011, Role of nuclear receptor corepressor RIP140 in metabolic syndrome, Biochimica et Biophysica Acta, 1812, 919, 10.1016/j.bbadis.2010.12.016

10.1158/0008-5472.CAN-13-3429

10.1016/j.cmet.2007.08.004

10.1210/me.2005-0504

10.1016/j.tem.2014.05.004

Stern, 2016, Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk, Cell Metabolism, 23, 770, 10.1016/j.cmet.2016.04.011

10.1242/dev.01966

10.1038/42652

10.1210/me.12.6.864

10.1042/BJ20090915

10.1210/en.2005-0348

van’t Veer, 2006, The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia, Haematologica, 91, 56

10.1128/MCB.21.18.6181-6188.2001

10.1152/ajpendo.00249.2011

10.1074/jbc.M004821200

10.1038/82183

Wieland, 1991, Interference and synergism of glucocorticoid receptor and octamer factors, EMBO Journal, 10, 2513, 10.1002/j.1460-2075.1991.tb07791.x

Wong, 2014, Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation, American Journal of Clinical and Experimental Urology, 2, 169

10.1038/nature12034

10.1074/jbc.R110.193367

10.1073/pnas.1121113109

10.1182/blood-2007-11-121699